| CTRI Number |
CTRI/2024/05/067936 [Registered on: 27/05/2024] Trial Registered Prospectively |
| Last Modified On: |
26/05/2024 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Medical Device |
| Study Design |
Randomized, Parallel Group, Active Controlled Trial |
|
Public Title of Study
|
Evaluation of the analgesia obtained by radiofrequency ablation versus chemical neurolysis (phenol) of splanchnic nerve in the management of upper abdominal chronic pain. |
|
Scientific Title of Study
|
Comparison of radiofrequency ablation versus
chemical neurolysis (phenol) of splanchnic
nerve in the management of chronic upper abdominal pain : A Randomised control trial |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Sridhar M |
| Designation |
Senior Resident (Acad) |
| Affiliation |
AIIMS Rishikesh |
| Address |
Department of anesthesia , Level 6 , AIIMS Campus , Virbhadra road , Rishikesh
Dehradun UTTARANCHAL 249203 India |
| Phone |
8197348627 |
| Fax |
|
| Email |
sridharmn819@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Praveen Talawar |
| Designation |
Additional Professor |
| Affiliation |
AIIMS Rishikesh |
| Address |
Department of anesthesia , Level 6 , AIIMS Rishikesh , Virbhadra Road
Dehradun UTTARANCHAL 249203 India |
| Phone |
9654162941 |
| Fax |
|
| Email |
praveenrt64@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Praveen Talawar |
| Designation |
Additional Professor |
| Affiliation |
AIIMS Rishikesh |
| Address |
Department of anesthesia , level 6 , AIIMS Rishikesh , Virbhadra road
Dehradun UTTARANCHAL 249203 India |
| Phone |
9654162941 |
| Fax |
|
| Email |
praveenrt64@gmail.com |
|
|
Source of Monetary or Material Support
|
| AIIMS Rishikesh , Virbhadra road , Rishikesh , Dehradhun , Pin Code - 249203 , India |
|
|
Primary Sponsor
|
| Name |
Sridhar M |
| Address |
Department of Anesthesia , Level 6 , AIIMS Rishikesh , Virbhadra road , Rishikesh , Dehradhun , Pin Code - 249203 , India |
| Type of Sponsor |
Other [self] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Sridhar M |
AIIMS Rishikesh |
Department of Anesthesia , Division Of Pain Medicine , Level 6 , AIIMS Rishikesh , Virbhadra road , Rishikesh , Dehradhun , Pin Code -249203 , India Dehradun UTTARANCHAL |
8197348627
sridharmn819@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| AIIMS RISHIKESH |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: O||Medical and Surgical, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
Chemical neurolysis (phenol) of Splanchnic nerve |
Applying the same procedural steps employed in the RF block, we will replicate the process
at the T11 vertebra using a 20-gauge 10 cm Chiba needle. However, instead of
thermocoagulation, we will go for bilateral chemical (phenol) neurolysis. The confirmation of
needle position was achieved by observing the distribution of 0.5 ml of contrast dye in both
anteroposterior (AP) and lateral views. A total volume of 12 ml of 6% was injected in two 6
ml doses, administered on each side of the T11 vertebra. To prevent track formation and
tissue necrosis due to phenol spread, 1 ml of 0.9% normal saline will be injected during the
withdrawal of the needle. |
| Intervention |
Radiofrequency ablation of Splanchnic nerve |
Under fluroscopy guidance ,a metal forceps guide will be placed on participant’s body, strategically positioning it so that the forceps tip projected precisely onto the lateral edge of the T10 vertebral body, positioned just below the costovertebral angle. This will become the designated entry point through the skin, strategically located within a 4 cm range from the spinous processes. akin to setting the stage for the subsequent steps, ensuring accuracy in the procedure. Following the application of local 2% lidocaine at the puncture site, the RF cannula (20- gauge, sharp curved, 100 mm length, 10 mm active tip) will carefully introduced and progressed with focused precision, utilizing an oblique view for a direct look at the needle;s
end-on appearance. The cannula is advanced with meticulous attention, ensuring a gradual and precise approach. Confirmation of the final placement occurred by examining a posteroanterior (PA) image, where the cannula tip established contact with the lateral border of the vertebra, positioned below the costovertebral angle. Double checking the depth of the cannula through a lateral view before advancing it further. Maintaining close proximity to the periosteum, the cannula is carefully progressed until its active tip reached the border region between the anterior and middle third of the vertebral body. We will replicate the procedure at the T11 level, removing the stylets from the radiofrequency (RF) cannula. Following this, electrodes will be introduced into the cannula and linked to the RF generator. To guarantee the accurate positioning of both cannulas at distinct levels and rule out somatic nerve interference, sensory stimulation ensued. This involved a 50 Hz RF pulse of 2 ms width and voltage maintained below 1.5 V, expecting participants to report
abdominal pain akin to their initial symptomatic pain or experience epigastric pressure. We will conduct motor stimulation using a 2 Hz RF pulse with a width of 2 ms and voltage kept below 3 V. It is emphasized that contractions of the intercostal muscles should be absent during stimulation; any observed contraction indicated that the active electrode tip was too proximal to the somatic intercostal nerve.The entire process was replicated on the opposite side.We will simultaneously generate four monopolar RF lesions at 85°C. Following a 90-second pause, an additional lesion was created after a 180-degree needle rotation, accompanied by repeated sensory and motor stimulation. Just before crafting each lesion, we will administered1 ml of dexamethasone (4 mg) and 2 ml of 2% lidocaine. |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
99.00 Year(s) |
| Gender |
Both |
| Details |
1)≥ 18 year of both sex who suffered from upper abdominal pain (visceral pain with VAS ≥4)for a duration of more than 3 months.
2) Â Patients who were taking the maximum tolerable dose of opioids.Â
3) Splanchnic nerve accessible for bilateral neurolysis. |
|
| ExclusionCriteria |
| Details |
1. Patient refusal,
2. Organ failure,
3. Coagulation disorders,
4. Local infection at the puncture site,
5. Sepsis,
6. Allergy to the contrast dye,
7. Pregnant women,
8. Psychiatric illness that affects cooperation |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
Change in pain NRS score from baseline to 3 months post
intervention. |
Baseline , 7 days , 1 month , 3 month |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
Change in karnofsky performance status scale from baseline to 3 months post
intervention. |
Baseline , 7 days , 1 month , 3 month |
| Change in sleep score from baseline to 3 months post intervention. |
Baseline , 7 days , 1 month , 3 month |
Change in Analgesic requirement (medication quantification scale) from baseline to 3
months post intervention. |
Baseline , 7 days , 1 month , 3 month |
|
|
Target Sample Size
|
Total Sample Size="50" Sample Size from India="50"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 4 |
|
Date of First Enrollment (India)
|
10/06/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
upper abdominal chronic pain can indeed be a burden , often indicative of various conditions . There are various modes of treatment for chronic abdominal pain not responding to conservative management which include splanchnic nerve neurolysis , celiac plexus neurolysis , implantable intrathecal drug delivering devices and spinal cord stimulators .Disparities in access to pain management resources add another layers of complexity , emphasizing the need for interventions that are not only effective but also adaptable to diverse healthcare landscapes . Hence we decided to do this study . |